摘要
胃癌是常见的恶性肿瘤之一,手术切除仍是主要的治疗手段。但进展期胃癌术后复发转移率很高,术胃癌是常见的恶性肿瘤之一,手术切除仍是主要的治疗手段。但进展期胃癌术后复发转移率很高,术后辅助化疗效果不佳。近年来,临床开展的新辅助化疗采用新的化疗药物(如多西紫杉醇)和新的化疗方案(如FOLFOX方案),效果满意,提高了手术切除率。本文对进展期胃癌的新辅助化疗现状做一综述。
Gastric cancer is one of the most common cancers all over the world. Surgery is the main treatment for gastric cancer. Advanced gastric cancer presents with a high recurrence rate At present, the survival benefit of postoperative chemotherapy is not satisfactory. In order to increase the number of patients for potential cu- rative surgery, researchers have begun to pay more attention on neoadjuvant chemotherapy. Some new drugs （Docetaxel） and new chemotherapy regimens （FOLFOX） have been developed recently. We reviewed the current status of neoadjuvant chemotherapy for advanced gastric cancer.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2008年第17期1018-1020,共3页
Chinese Journal of Clinical Oncology
关键词
晚期胃癌
新辅助化疗
恶性肿瘤
Advanced gastric cancer
Neoadjuvant chemotherapy
Malignant tumor
